Tag: nasal vaccine

First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial

Source: PIB What is the News? BBV154, the first Nasal Vaccine against Covid-19 has received the regulator’s nod for conducting Phase 2 and 3 clinical trials. About BBV154: BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. It is the first Intranasal Covid-19 Vaccine being developed by Bharat Biotech. Click Here to read about… Continue reading First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial